PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-05-01

Date Title Company
01-May-2023 SunMed Completes Acquisition of Respiratory & Anesthesia Consumables Business of Vyaire Medical Businesswire
01-May-2023 Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of adidas AG (ADDYY, ADDDF) on Behalf of Investors Businesswire
01-May-2023 IGEA Pharma N.V.: IGEA to get SIX approval to Annual Report 2022 disclosure IGEA Pharma N.V.
01-May-2023 Hanger Announces Pete Stoy as CEO Businesswire
01-May-2023 Alcon Announces Largest-Ever Scientific Presence at ASCRS 2023 and Expands Image-Guided Connectivity Businesswire
01-May-2023 Tivic Announces Appointment of New Interim CFO, Kimberly Bambach, and Strategic Advisor to the Board, Christine Valauri Businesswire
01-May-2023 ImmunoTek Plasma Opens New Location in Baton Rouge Businesswire
01-May-2023 AleraCare Rebrands Nationally and Consolidates Ambulatory Infusion, Specialty Pharmacy, Home Infusion and Compounding Pharmacy Service Lines Businesswire
01-May-2023 Athersys to Participate in The Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Conference Businesswire
01-May-2023 OmniAb to Report First Quarter 2023 Financial Results on May 11 Businesswire
01-May-2023 Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths Innovations Limited Businesswire
01-May-2023 Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer Businesswire
01-May-2023 Horizon Therapeutics plc Announces Initiation of Phase 3 Clinical Trial in Japan Evaluating TEPEZZA® (teprotumumab-trbw) in Adults with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) Businesswire
01-May-2023 bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer Businesswire
01-May-2023 Charles River Laboratories Launches Next Generation Sequencing Services for Bacterial Identification and Fungal ID Businesswire
01-May-2023 COEUS Holdings Announces Rebranding to Reflect the Unification of Each Business Unit Into One Entity Businesswire
01-May-2023 U.S. FDA Accepts for Priority Review Supplemental Biologics License Application and EMA Validates Application for Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Businesswire
01-May-2023 Great Point Partners Expands Transatlantic Value Creation Through London Office Opening Businesswire
01-May-2023 Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting Businesswire
01-May-2023 Silence Therapeutics Completes Enrollment in Phase 2 Study of Zerlasiran (SLN360) in Subjects with Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events Businesswire